Karyopharm Therapeutics Inc. (KPTI) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$8.27
Day's range
$8.96

Karyopharm Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
COMMODORE CAPITAL LP 05/15/2026 1.95 M $10.86 M   100.00% 8.86%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 1.92 M $10.68 M   100.00% 8.71%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 1.81 M $10.06 M   328.73% 8.21%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 1.54 M $8.59 M   3.40% 7.01%
CAPTION MANAGEMENT, LLC 05/15/2026 1.09 M $6.05 M   100.00% 4.94%
GOLDMAN SACHS GROUP INC 05/15/2026 947.58 K $5.28 M   100.00% 4.30%
IKARIAN CAPITAL, LLC 05/15/2026 920.00 K $5.12 M   100.00% 4.18%
CATALIO CAPITAL MANAGEMENT, LP 05/15/2026 897.71 K $5.00 M   527.84% 4.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 865.00 K $4.82 M   169.55% 3.93%
05/15/2026 750.00 K $4.18 M   100.00% 3.41%
05/15/2026 739.75 K $4.12 M   100.00% 3.36%
IKARIAN CAPITAL, LLC 05/15/2026 733.44 K $4.09 M   34.69% 3.33%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 500.00 K $2.79 M   -43.79% 2.27%
JANE STREET GROUP, LLC 05/12/2026 473.40 K $2.64 M   2,255.22% 2.15%
AVIDITY PARTNERS MANAGEMENT LP 05/28/2026 463.74 K $2.58 M   244.62% 2.11%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 440.00 K $2.45 M   0.00% 2.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 425.90 K $2.37 M   16.27% 1.93%
MILLENNIUM MANAGEMENT LLC 05/15/2026 420.57 K $2.34 M   100.00% 1.91%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 302.54 K $1.69 M   19.80% 1.37%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 05/15/2026 300.00 K $1.67 M   -3.23% 1.36%
ACORN CAPITAL ADVISORS, LLC 05/15/2026 287.83 K $1.60 M   100.00% 1.31%
EVERSEPT PARTNERS, LP 05/15/2026 276.17 K $1.54 M   100.00% 1.25%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 268.30 K $1.49 M   100.00% 1.22%
JUMP FINANCIAL, LLC 05/14/2026 262.15 K $1.46 M   387.12% 1.19%
CITADEL ADVISORS LLC 05/15/2026 258.20 K $1.44 M   694.46% 1.17%
TREXQUANT INVESTMENT LP 05/15/2026 257.90 K $1.44 M   517.98% 1.17%
ALLY BRIDGE GROUP (NY) LLC 05/18/2026 250.00 K $1.39 M   100.00% 1.14%
CITADEL ADVISORS LLC 05/15/2026 249.30 K $1.39 M   249.65% 1.13%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 248.96 K $1.38 M   6,581.62% 1.13%
BLACKROCK, INC. 05/13/2026 244.90 K $1.36 M   -1.07% 1.11%
DIADEMA PARTNERS LP 05/15/2026 241.30 K $1.34 M   100.00% 1.10%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 213.81 K $1.19 M   47.83% 0.97%
BREVAN HOWARD CAPITAL MANAGEMENT LP 05/15/2026 212.37 K $1.18 M   100.00% 0.96%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 206.13 K $1.15 M   9.80% 0.94%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 205.20 K $1.14 M   100.00% 0.93%
UBS GROUP AG 05/05/2026 194.02 K $1.08 M   119.34% 0.88%
GROUP ONE TRADING, L.P. 05/13/2026 191.53 K $1.07 M   87.00% 0.87%
XTX TOPCO LTD 05/15/2026 164.44 K $915.95 K   1,281.41% 0.75%
TWO SIGMA INVESTMENTS, LP 05/15/2026 151.23 K $842.36 K   1.64% 0.69%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 136.74 K $761.62 K   173.47% 0.62%
MARSHALL WACE, LLP 05/15/2026 128.45 K $715.47 K   0.00% 0.58%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 114.93 K $640.18 K   100.00% 0.52%
ENGINEERS GATE MANAGER LP 05/15/2026 112.43 K $626.25 K   100.00% 0.51%
JANE STREET GROUP, LLC 05/12/2026 105.90 K $589.87 K   198.04% 0.48%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 105.41 K $587.16 K   75.94% 0.48%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 100.00 K $557.00 K   100.00% 0.45%
SILVERBACK ASSET MANAGEMENT LLC 05/21/2026 100.00 K $557.00 K   100.00% 0.45%
C WORLDWIDE GROUP HOLDING A/S 05/06/2026 100.00 K $557.00 K   0.00% 0.45%
CAPTION MANAGEMENT, LLC 05/15/2026 95.00 K $529.15 K   100.00% 0.43%
MILLENNIUM MANAGEMENT LLC 05/15/2026 91.00 K $506.87 K   100.00% 0.41%

Karyopharm Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 119 institutional investors and hedge funds held shares of Karyopharm Therapeutics Inc. The most heavily invested institutionals were:

COMMODORE CAPITAL LP: 1.95 M

RA CAPITAL MANAGEMENT, L.P.: 1.92 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 1.81 M

T. Rowe Price Investment Management, Inc.: 1.54 M

GOLDMAN SACHS GROUP INC: 947,579

Catalio Capital Management, LP: 897,709

83.27% of Karyopharm Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 28.15 M shares in the last 24 months. This purchase volume represents approximately $239.03 M in transactions.